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Abstract: FurinDB (freely available online at http://www.nuolan.net/substrates.html) is a 
database of furin substrates. This database includes experimentally verified furin cleavage 
sites, substrates, species, experimental methods, original publications of experiments and 
associated drugs targeting furin substrates. The current database release contains 126 furin 
cleavage sites from three species: mammals, bacteria and viruses. A main feature of this 
database is that all furin cleavage sites are recorded as a 20-residue motif, including one 
core  region  (eight  amino  acids,  P6–P2’)  and  two  flanking  solvent  accessible  regions 
(eight amino acids, P7–P14, and four amino acids, P3’–P6’), that represent our current 
understanding of the molecular biology of furin cleavage. This database is important for 
understanding  the  molecular  evolution  and  relationships  between  sequence  motifs, 
3D structures, cellular functions and physical properties required by furin for cleavage, and 
for elucidating the molecular mechanisms and the progression of furin cleavage associated 
human  diseases,  including  pathogenic  infections,  neurological  disorders,  tumorigenesis, 
tumor invasion, angiogenesis, and metastasis. FurinDB database will be a solid addition to 
the publicly available infrastructure for scientists in the field of molecular biology. 
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1. Introduction  
In the secretory pathway, many proteins are initially synthesized as inactive protein precursors, and 
proteolytic cleavage of these protein precursors by furin is an important step in the production of 
biologically  active  proteins  [1,2].  Functionally,  furin  has  two  main  subcellular  localizations:  the  
trans-Golgi network and the cell surface. In the trans-Golgi network, furin cleaves and activates most 
host  substrates,  including  extracellular  matrix  proteins,  signaling  peptides,  growth  factors,  serum 
proteins,  cell  surface  transmembrane  receptors  and  ion  channels  [1,2].  On  the  cell  surface,  furin 
cleaves many pathogenic substrates, such as bacterial toxins and viral fusion peptides. Maturation of 
functional proteins by furin cleavage is known to be involved in a wide range of human diseases, such 
as  pathogenic  infections,  neurological  disorders,  tumorigenesis,  tumor  invasion,  angiogenesis  and 
tumor metastasis [1,2]. Recently, the use of the furin cleavage motif for targeted drug delivery in the 
treatment of tumors has been demonstrated [3].  
An important step in furin cleavage is the recognition of specific cleavage site motifs presented by 
furin substrates. Furin’s consensus cleavage site motif was widely reported to be a canonical four 
amino acid motif R-X-[KR]-R↓. In one of the author’s recent work, instead of this four amino acid 
motif,  the  furin  cleavage  site  has  been  characterized  as  a  20  amino  acid  motif  running  from  the  
P14–P6’  region, which  can  be divided  into one  core region (eight  amino acids, P6–P2’) and two 
flanking solvent accessible regions (eight amino acids, P7–P14, and four amino acids, P3’–P6’) [4]. 
The backward numbering (P1–P14) and forward numbering (P1’–P6’) starts at the conserved arginine 
immediately prior to the furin cleavage site. The favored physical properties of each region required 
for interaction with the furin binding pocket and the solvent accessibility of furin substrates have been 
revealed  (Figure  1)  [4].  In  mammals,  bacteria  and  viruses,  the  evolutionarily  conserved  physical 
properties of furin cleavage site motifs are evident, and the dynamic relationship between the physical 
properties of the P1’–P6’ region and both cellular function and viral infection has been analyzed with 
respect  to  different  species  [4].  Using  this  updated  understanding  of  the  sequence  motif  and  the 
molecular biology of furin cleavage, in this work, we have developed the FurinDB database. This 
database aims to facilitate further studies into the molecular biology of furin cleavage, the molecular 
mechanisms of its associated human diseases, and possible therapeutic treatments. The current version 
of
  FurinDB  is  a  collection  of  126 experimental  data  of  known  furin  cleavage  sites.  It  contains 
information about the amino acid residues in furin cleavage sites, the presence of multiple cleavage 
sites  in  the  same  protein,  furin  substrates,  substrate  species,  experimental  methods,  original 
publications and associated drugs that target furin substrates. Substrates are grouped according to their 
biological functional categories and taxonomy.  Int. J. Mol. Sci. 2011, 12                       
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Figure  1. Physical properties of the 20 residue furin cleavage site motif. The physical 
properties  of  this  motif  have  been  conserved  in  molecular  evolution.  Distinct  physical 
properties at different regions in the site affect the molecular biology of furin cleavage. The 
dynamic  relationship  between  the  physical  properties  of  the  P1’–P6’  region  and  viral 
infectivity is explained. The figure is reproduced from the author’s previous publication [4]. 
P10  P9  P8  P7 P6    P5    P4    P3    P2    P1 P1’P2’ P1’ P2’ P3’ P4’ P14  P13  P12  P11
Furin cleavage site
P7-P10: Solvent accessible region. 
Small and hydrophilic residues are 
favoured, and the polar side chains 
may form weak interactions with 
polar surface of furin.
P3’-P6’: Solvent accessible region. 
Small and hydrophilic residues are 
favored, and the polar side chains 
may form weak interactions with 
polar surface of furin. 
Viral substrates may have no 
hydrophilic residues in this region. 
This hydrophobicity may reduce 
furin cleavage efficiency, but is 
required for viral fusion. Viral 
substrates solve this problem by 
using a fine tuned composition of 
small hydrophobic amino acids in 
this region. 
P2’: Aliphatic or hydrophobic 
residues are favoured
P1:Arginine P4: positively charged 
residues are favoured, 
aliphatic residues are 
accepted
P1-P6: Generally a positively charged region, or generally 
residues with high isoelectric point  are favoured. Presence of 
cysteine in this region may reduce furin cleavage efficiency.
P1’: Small, particularly small hydrophilic 
residues are favoured. Negatively 
charged residues are accepted. Limitation 
of residue volume exists. 
Glycosylation of residue at this position 
may alter the side chain volume and 
reduce furin cleavage efficiency
P4-P6: Compensatory 
effect for positive charge
P2-P3: Flexible, 
not to be too rigid P11-P14: solvent accessible region
P2: Arginine, lysine or 
very small flexible 
residues are favoured
 
We expect FurinDB to be a useful resource in the study of the molecular evolution and molecular 
biology of furin cleavage site motifs, as well as the elucidation of the molecular mechanisms
 and the 
progression of furin cleavage mediated human diseases, such as pathogenic infections, neurological 
disorders, tumorigenesis, tumor invasion, angiogenesis, and metastasis.  
2. Results and Discussion  
2.1. Database Content 
Currently, the FurinDB database contains 126 cleavage sites from 110 substrates originating from 
three species [4], as well as 15 associated drugs that have either already been approved by the FDA or 
are  in  trials.  All  substrates,  cleavage  sites  and  original  experimental  records  were  collected  from  
peer-reviewed  literature  [4].  The  drug  targets  were  identified  by  querying  against  Ingenuity 
Knowledge Base. The FurinDB database was developed using PHP 5 and MySQL database. Int. J. Mol. Sci. 2011, 12                       
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Each cleavage site is considered an entry, and each entry includes the following information:
  
1. Furin substrate sequence information: Name and description of the gene encoding the substrate 
protein and
 the substrate protein ID. External links to the NCBI protein sequence database and 
the NCBI Entrez gene database are also provided. 
2. Furin  cleavage  site  sequence  information  and  location:  The  furin  cleavage  site  P14–P6’  is 
represented  as  a  20  amino  acids  motif  that  contains  one  core  region  (eight  amino  acids,  
positions P6–P2’) packed inside the furin binding pocket; and two polar regions (eight amino 
acids, positions P7–P14; and four amino acids, positions P3’–P6’) located outside of the furin 
binding pocket [4]. The position P1, immediately prior to the furin cleavage site is recorded. The 
presence of multiple cleavage sites on the same protein substrate is indicated. 
3. Taxonomy information of substrate: Each furin substrate is assigned to one of three taxonomy 
groups (mammals, bacteria or viruses).  
4. Functional information about the furin substrates: Each furin substrate is assigned to one of 
seven  predefined  biological  functions:  (1)  extracellular  matrix  protein;  (2)  signal  peptide, 
hormone or  growth factor; (3)  serum  protein;  (4)  transmembrane  receptor;  (5) viral protein; 
(6) bacterial protein or (7) other [1,2]. 
5. Experimental methods and conditions: Methods used to measure furin cleavage and the final 
cleavage products, the origin of the furin enzyme and the origin of the furin substrate used in the 
experiment and the literature record of the original experiments. These detailed experimental 
methods and conditions are grouped into 10 different types [5]. External links to the PUBMED 
literature database are also provided. 
6. Associated drugs: Information is included for each furin substrate targeted by a drug that has 
either entered phase I trials or has already received FDA approval. 
2.2. Database Access and Web Interface 
The FurinDB database is publicly accessible through a web interface [5]. The website provides 
three  different  ways  to  facilitate  searching  the  database,  with  different  queries  for  gene  name, 
biological function, taxonomy, drug availability and furin cleavage site motif.  
Three different search methods have been implemented in the database:  
1. Query  by  seven  functional  categories,  three  species  and  if  the  furin  substrate  is  a  known 
drug target. 
2. Query by standard Entrez gene name.  
3. Query by the eight amino acids motif in the core region P6–P2’ of the furin cleavage site, which 
is located inside the furin binding pocket. Either one or multiple amino acids can be input at any 
of the eight positions. The symbol X is interpreted to mean any amino acid. 
Query  results  are  displayed  in  table  form  (Figure  2).  The  core  region  (eight  amino  acids,  
positions  P6–P2’),  which  is  packed  inside  the  furin  binding  pocket,  is  displayed  in  blue,  and  the 
arginine at position P1 immediately prior to the furin cleavage site is displayed in red. Int. J. Mol. Sci. 2011, 12                       
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Figure 2. Screenshot of the FurinDB database. Information of substrates, cleavage sites, 
taxonomies, biological functions, experimental methods and associated drugs are displayed 
in table form. 
 
3. Future Development 
Future  directions  for  development  of  the  database  include  two  parts:  (1)  We  aim  to  collect 
additional furin substrates from the literature and extend this effort to include other members of the 
mammalian proprotein convertase family [6,7]. Furthermore, given the fact that many furin substrates 
are involved in growth, proliferation and extracellular matrix remodeling, we  anticipate that more 
drugs, particularly anti-cancer drugs, will be developed to target furin substrates. This effort will be 
aided by the novel design of specific small molecular inhibitors targeting individual members of the 
mammalian  proprotein  convertase  family.  These  specific  small  molecules  are  predicted  to  be 
derivatives of the short peptide pattern [K/R]-X-V-X-K-R [8]. Database information on furin substrate 
associated drugs will be regularly updated; (2) An algorithm for the prediction of location and presence 
of furin cleavage sites in protein sequences is currently being tested. The webserver for this prediction 
tool will be running along with the database, and it will also be freely available at the same web site 
which hosts the FurinDB.  Int. J. Mol. Sci. 2011, 12                       
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4. Conclusions 
We have developed FurinDB, a database of experimentally verified furin cleavage sites, substrates 
and associated drugs targeting furin substrates. All data is freely available at [5]. The database will be a 
valuable  tool  for  studying  the  molecular  biology  and  molecular  evolution  of  furin  cleavage  sites, 
as well  as  elucidating  the  molecular  mechanisms  and  progression
  of  furin  cleavage  associated 
human diseases. 
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